Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
British Journal of Cancer|October 28, 2005
Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancerG G Van den Eynden, I Van der Auwera, S J Van Laere, et al.British Journal of Cancer|March 6, 2003
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expressionC G Colpaert, P B Vermeulen, I Benoy, et al.British Journal of Cancer|April 1, 2004
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxiaF Stessels, G Van den Eynden, I Van der Auwera, et al.Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 14, 2015
Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant TherapyR L Eefsen, L Engelholm, W Alpizar-Alpizar, et al.British Journal of Cancer|April 7, 2011
Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancerD J E Peeters, G G Van den Eynden, P-J van Dam, et al.Breast Cancer Research and Treatment|March 25, 2004
Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancerG G Van den Eynden, I Van der Auwera, S Van Laere, et al.British Journal of Cancer|February 26, 2009
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancerX B Trinh, W A A Tjalma, P B Vermeulen, et al.British Journal of Cancer|December 25, 2013
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypesD J E Peeters, P-J van Dam, G G M Van den Eynden, et al.Oncology Reports|December 3, 2011
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerX B Trinh, L Sas, S J Van Laere, et al.British Journal of Cancer|October 9, 2008
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeI Van der Auwera, S J Van Laere, S M Van den Bosch, et al.Pageof 6